Induction and Concurrent Taxanes Enhance Both the Pulmonary Metabolic Radiation Response and the Radiation Pneumonitis Response in Patients With Esophagus Cancer
Open Access
- 1 March 2010
- journal article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 76 (3), 816-823
- https://doi.org/10.1016/j.ijrobp.2009.02.059
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Induction chemotherapy with paclitaxel plus carboplatin followed by paclitaxel with concurrent radiotherapy in stage IIIB non-small-cell lung cancer (NSCLC) patients: A phase II trialLung Cancer, 2007
- Attenuation correction of PET cardiac data with low‐dose average CT in PET/CTMedical Physics, 2006
- Radiation Pneumonitis in Breast Cancer Patients Treated with Taxanes: Does Sequential Radiation Therapy Lower the Risk?The Breast Journal, 2005
- Clinically Relevant Pneumonitis After Sequential Paclitaxel-Based Chemotherapy and Radiotherapy in Breast Cancer PatientsJNCI Journal of the National Cancer Institute, 2004
- CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatmentSeminars in Radiation Oncology, 2003
- In vivoassessment of lung inflammatory cell activity in patients with COPD and asthmaEuropean Respiratory Journal, 2003
- Automatic lung segmentation for accurate quantitation of volumetric X-ray CT imagesIEEE Transactions on Medical Imaging, 2001
- THE DEVELOPMENT AND CLINICAL UTILITY OF THE TAXANE CLASS OF ANTIMICROTUBULE CHEMOTHERAPY AGENTSAnnual Review of Medicine, 1997
- The taxoids: paclitaxel (Taxol®) and docetaxel (Taxotere®)Cancer Treatment Reviews, 1993
- Use of Ranks in One-Criterion Variance AnalysisJournal of the American Statistical Association, 1952